These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 4722913)
21. Proceedings: Malignant lymphoma: treatment with combination chemotherapy. De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651 [No Abstract] [Full Text] [Related]
22. [Vinblastine + procarbazine + cyclophosphamide association in the treatment of Hodgkin's disease (author's transl)]. Chauvergne J; Hoerni B; Hoerni-Simon G; Durand M; Lagarde C Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1973 Nov; 80(2):179-88. PubMed ID: 4271955 [No Abstract] [Full Text] [Related]
23. The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly. Desser RK; Ultmann JE Ser Haematol; 1973; 6(2):152-81. PubMed ID: 4131662 [No Abstract] [Full Text] [Related]
24. BCNU, velban, cyclophosphamide, procarbazine, and prednisone (BVCPP) in advanced Hodgkin's disease. Durant JR; Gams RA; Velez-Garcia E; Bartolucci A; Wirtschafter D; Dorfman R Cancer; 1978 Nov; 42(5):2101-10. PubMed ID: 719600 [No Abstract] [Full Text] [Related]
26. Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group. Gams RA; Durant JR; Bartolucci AA Cancer Treat Rep; 1982 Apr; 66(4):899-905. PubMed ID: 7042089 [TBL] [Abstract][Full Text] [Related]
27. BCNU (NSC-409962) in the treatment of advanced Hodgkin's disease, lymphosarcoma, and reticulum cell sarcoma. Rege VB; Owens AH Cancer Chemother Rep; 1974; 58(3):383-92. PubMed ID: 4601668 [No Abstract] [Full Text] [Related]
28. Status and perspectives in chemotherapy of Hodgkin's disease. Frei E Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436 [No Abstract] [Full Text] [Related]
29. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group. Glick JH; Barnes JM; Bakemeier RF; Prosnitz LR; Bennett JM; Neiman RS; Costello W; Orlow EL Cancer Treat Rep; 1982 Apr; 66(4):855-70. PubMed ID: 7042087 [TBL] [Abstract][Full Text] [Related]
30. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia. Frei E; Schabel FM; Goldin A Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419 [No Abstract] [Full Text] [Related]
31. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma. Durant JR; Gams RA; Bartolucci AA; Dorfman RF Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345 [TBL] [Abstract][Full Text] [Related]
32. Letter: Chemotherapy of Hodgkin's disease. Winokur SH N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438 [No Abstract] [Full Text] [Related]
33. Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease. Bartolucci AA; Liu C; Durant JR; Gams RA Cancer; 1983 Dec; 52(12):2209-13. PubMed ID: 6580060 [TBL] [Abstract][Full Text] [Related]
35. Combination chemotherapy in Hodgkin's disease. Nordentoft AM; Jensen KB Dan Med Bull; 1973 Mar; 20(2):52-60. PubMed ID: 4688460 [No Abstract] [Full Text] [Related]
36. [Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis]. Boiron M; Teillet F; Weisgerber C; Dana M; Jacquillat C; Bernard J Rev Prat; 1974 Oct; 24(45):3971-8. PubMed ID: 4445767 [No Abstract] [Full Text] [Related]
37. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine. Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216 [No Abstract] [Full Text] [Related]
38. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease. Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551 [No Abstract] [Full Text] [Related]